CAYMAN CHEMICAL COMPANY Non-Antibody Products — page 840 of 870
Non-Antibody Products
Page 840 of 870
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Ursocholic Acid | A bile acid; dietary administration decreases gallbladder cholesterol, pho… | 1 mg | 29883-1 | More Info |
| Ursocholic Acid | A bile acid; dietary administration decreases gallbladder cholesterol, pho… | 10 mg | 29883-10 | More Info |
| Ursocholic Acid | A bile acid; dietary administration decreases gallbladder cholesterol, pho… | 5 mg | 29883-5 | More Info |
| Ursocholic Acid-d4 | An internal standard for the quantification of ursocholic acid by GC- or L… | 1 mg | 35419-1 | More Info |
| Ursocholic Acid-d4 | An internal standard for the quantification of ursocholic acid by GC- or L… | 10 mg | 35419-10 | More Info |
| Ursocholic Acid-d4 | An internal standard for the quantification of ursocholic acid by GC- or L… | 5 mg | 35419-5 | More Info |
| Ursodeoxycholic Acid | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 1 g | 31016-1 | More Info |
| Ursodeoxycholic Acid | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 5 g | 31016-5 | More Info |
| Ursodeoxycholic Acid-d4 | An internal standard for the quantification of ursodeoxycholic acid by GC-… | 1 mg | 21892-1 | More Info |
| Ursodeoxycholic Acid-d4 | An internal standard for the quantification of ursodeoxycholic acid by GC-… | 5 mg | 21892-5 | More Info |
| Ursodeoxycholic Acid-d4 | An internal standard for the quantification of ursodeoxycholic acid by GC-… | 500 µg | 21892-500 | More Info |
| Ursodeoxycholic Acid-d4 MaxSpec® Standard | A quantitative analytical standard guaranteed to meet MaxSpec® identit… | 100 µg | 31368-100 | More Info |
| Ursodeoxycholic Acid MaxSpec® Standard | A quantitative analytical standard guaranteed to meet MaxSpec® identit… | 100 µg | 31367-100 | More Info |
| Ursodeoxycholic Acid (sodium salt) | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 1 g | 15121-1 | More Info |
| Ursodeoxycholic Acid (sodium salt) | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 250 mg | 15121-250 | More Info |
| Ursodeoxycholic Acid (sodium salt) | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 5 g | 15121-5 | More Info |
| Ursodeoxycholic Acid (sodium salt) | A secondary bile acid; formed via epimerization of CDCA; a metabolite of L… | 500 mg | 15121-500 | More Info |
| Ursolic Acid | A pentacyclic triterpenoid with diverse biological activities; inhibits th… | 100 mg | 10072-100 | More Info |
| Ursolic Acid | A pentacyclic triterpenoid with diverse biological activities; inhibits th… | 250 mg | 10072-250 | More Info |
| Ursolic Acid | A pentacyclic triterpenoid with diverse biological activities; inhibits th… | 50 mg | 10072-50 | More Info |
| Urumin (trifluoroacetate salt) | An H1-selective influenza antiviral; inhibits H1 hemagglutinin-containing… | 500 µg | 24277-500 | More Info |
| Usaramine | A pyrrolizidine alkaloid with antibacterial and hepatotoxic activities; re… | 1 mg | 34894-1 | More Info |
| Usaramine | A pyrrolizidine alkaloid with antibacterial and hepatotoxic activities; re… | 10 mg | 34894-10 | More Info |
| Usaramine | A pyrrolizidine alkaloid with antibacterial and hepatotoxic activities; re… | 25 mg | 34894-25 | More Info |
| Usaramine | A pyrrolizidine alkaloid with antibacterial and hepatotoxic activities; re… | 5 mg | 34894-5 | More Info |
| U-46619 serinol amide | A derivative of U-46619 | 1 mg | 40870-1 | More Info |
| U-46619 serinol amide | A derivative of U-46619 | 5 mg | 40870-5 | More Info |
| U-46619 serinol amide | A derivative of U-46619 | 500 µg | 40870-500 | More Info |
| Usmarapride (oxalate) | A 5-HT4 partial agonist; induces reporter gene expression in CHO cells exp… | 1 mg | 35867-1 | More Info |
| Usmarapride (oxalate) | A 5-HT4 partial agonist; induces reporter gene expression in CHO cells exp… | 10 mg | 35867-10 | More Info |
| Usmarapride (oxalate) | A 5-HT4 partial agonist; induces reporter gene expression in CHO cells exp… | 5 mg | 35867-5 | More Info |
| Usnic Acid | A lichen metabolite with antioxidant, anticancer, antifungal, antiprotozoa… | 1 g | 22585-1 | More Info |
| Usnic Acid | A lichen metabolite with antioxidant, anticancer, antifungal, antiprotozoa… | 10 g | 22585-10 | More Info |
| Usnic Acid | A lichen metabolite with antioxidant, anticancer, antifungal, antiprotozoa… | 25 g | 22585-25 | More Info |
| Usnic Acid | A lichen metabolite with antioxidant, anticancer, antifungal, antiprotozoa… | 5 g | 22585-5 | More Info |
| USP2 active domain (human recombinant) | Source: C-terminally Histidine-tagged human USP2 enzyme (active catalytic… | 100 µg | 22784-100 | More Info |
| USP7-USP47 Inhibitor | A dual inhibitor of USP7 and USP47 (IC50s = 0.42 and 1 µM, respectiv… | 1 mg | 25622-1 | More Info |
| USP7-USP47 Inhibitor | A dual inhibitor of USP7 and USP47 (IC50s = 0.42 and 1 µM, respectiv… | 10 mg | 25622-10 | More Info |
| USP7-USP47 Inhibitor | A dual inhibitor of USP7 and USP47 (IC50s = 0.42 and 1 µM, respectiv… | 5 mg | 25622-5 | More Info |
| UT-11 | An mPGES-1 inhibitor; inhibits PGE2 production in both SK-N-AS human and B… | 1 mg | 38580-1 | More Info |
| UT-11 | An mPGES-1 inhibitor; inhibits PGE2 production in both SK-N-AS human and B… | 10 mg | 38580-10 | More Info |
| UT-11 | An mPGES-1 inhibitor; inhibits PGE2 production in both SK-N-AS human and B… | 5 mg | 38580-5 | More Info |
| UTP (sodium salt) | A nucleotide and dual P2Y2 and P2Y4 receptor agonist (EC50s = 55 and 80 nM… | 1 g | 9003530-1 | More Info |
| UTP (sodium salt) | A nucleotide and dual P2Y2 and P2Y4 receptor agonist (EC50s = 55 and 80 nM… | 100 mg | 9003530-100 | More Info |
| UTP (sodium salt) | A nucleotide and dual P2Y2 and P2Y4 receptor agonist (EC50s = 55 and 80 nM… | 5 g | 9003530-5 | More Info |
| UTP (sodium salt) | A nucleotide and dual P2Y2 and P2Y4 receptor agonist (EC50s = 55 and 80 nM… | 500 mg | 9003530-500 | More Info |
| UTX (human, recombinant) | Source: Active recombinant N-terminal proprietary tagged protein expressed… | 25 µg | 10774-25 | More Info |
| Uvaol | A pentacyclic triterpenoid; induces cell cycle arrest at the G0 / G1 phase… | 10 mg | 33915-10 | More Info |
| Uvaol | A pentacyclic triterpenoid; induces cell cycle arrest at the G0 / G1 phase… | 25 mg | 33915-25 | More Info |
| Uvaol | A pentacyclic triterpenoid; induces cell cycle arrest at the G0 / G1 phase… | 50 mg | 33915-50 | More Info |
| UVI3003 | A full antagonist of RXR that demonstrates potent, nanomolar binding affin… | 10 mg | 16026-10 | More Info |
| UVI3003 | A full antagonist of RXR that demonstrates potent, nanomolar binding affin… | 5 mg | 16026-5 | More Info |
| UVI3003 | A full antagonist of RXR that demonstrates potent, nanomolar binding affin… | 50 mg | 16026-50 | More Info |
| 1V209 | A benzoic-acid modified purine; 1V209-polysaccharide conjugates increase T… | 10 mg | 38318-10 | More Info |
| 1V209 | A benzoic-acid modified purine; 1V209-polysaccharide conjugates increase T… | 25 mg | 38318-25 | More Info |
| 1V209 | A benzoic-acid modified purine; 1V209-polysaccharide conjugates increase T… | 5 mg | 38318-5 | More Info |
| 1V209 | A benzoic-acid modified purine; 1V209-polysaccharide conjugates increase T… | 50 mg | 38318-50 | More Info |
| V-125 | An RXR agonist; induces homodimerization of RXR in HCT116 cells in a two-h… | 100 mg | 37532-100 | More Info |
| V-125 | An RXR agonist; induces homodimerization of RXR in HCT116 cells in a two-h… | 25 mg | 37532-25 | More Info |
| V-125 | An RXR agonist; induces homodimerization of RXR in HCT116 cells in a two-h… | 5 mg | 37532-5 | More Info |
| V-9302 | An inhibitor of ASCT2; inhibits glutamine uptake (IC50s = 9 and 9.6 µ… | 1 mg | 27688-1 | More Info |
| V-9302 | An inhibitor of ASCT2; inhibits glutamine uptake (IC50s = 9 and 9.6 µ… | 10 mg | 27688-10 | More Info |
| V-9302 | An inhibitor of ASCT2; inhibits glutamine uptake (IC50s = 9 and 9.6 µ… | 25 mg | 27688-25 | More Info |
| V-9302 | An inhibitor of ASCT2; inhibits glutamine uptake (IC50s = 9 and 9.6 µ… | 5 mg | 27688-5 | More Info |
| Vaborbactam | A β-lactamase inhibitor (Kis = 29-110 nM for class A and class C enzy… | 1 mg | 23962-1 | More Info |
| Vaborbactam | A β-lactamase inhibitor (Kis = 29-110 nM for class A and class C enzy… | 10 mg | 23962-10 | More Info |
| Vaborbactam | A β-lactamase inhibitor (Kis = 29-110 nM for class A and class C enzy… | 5 mg | 23962-5 | More Info |
| Vacquinol-1 | An activator of MKK4-dependent macropinocytotic cell death in glioblastoma… | 1 mg | 16321-1 | More Info |
| Vacquinol-1 | An activator of MKK4-dependent macropinocytotic cell death in glioblastoma… | 10 mg | 16321-10 | More Info |
| Vacquinol-1 | An activator of MKK4-dependent macropinocytotic cell death in glioblastoma… | 25 mg | 16321-25 | More Info |
| Vacquinol-1 | An activator of MKK4-dependent macropinocytotic cell death in glioblastoma… | 5 mg | 16321-5 | More Info |
| Vacuolin-1 | A cell-permeable inhibitor of lysosomal exocytosis that prevents Ca2+-depe… | 1 mg | 20425-1 | More Info |
| Vacuolin-1 | A cell-permeable inhibitor of lysosomal exocytosis that prevents Ca2+-depe… | 10 mg | 20425-10 | More Info |
| Vacuolin-1 | A cell-permeable inhibitor of lysosomal exocytosis that prevents Ca2+-depe… | 25 mg | 20425-25 | More Info |
| Vacuolin-1 | A cell-permeable inhibitor of lysosomal exocytosis that prevents Ca2+-depe… | 5 mg | 20425-5 | More Info |
CAYMAN CHEMICAL COMPANY
CAYMAN CHEMICAL COMPANY
1180 East Ellsworth Road
Ann Arbor MI 48108
P: (734) 971-3335
P: (800) 364-9897 (USA & Canada only)
F: (734) 971-3640
Customer Service: custserv@caymanchem.com
Technical Support: techserv@caymanchem.com
Sales: sales@caymanchem.com
http://www.caymanchem.com
Return to Profile